$CYTX,
Stock for Your Portfolio: Cytori Therapeutics Inc (NASDAQ:CYTX)
By Robin Evans -
May 9, 2016
Share on Facebook
Tweet on Twitter
Financial data analyzing. Counting on calculator. Close-up. Selective focus
Share of Cytori Therapeutics Inc (NASDAQ:CYTX) traded on 4.44 percent above secure line at 2:40PM EDT in order to take the company’s stock at the price of $0.261. At the time of writing the stock exchanged hands 1.91 million shares versus average trading capacity of 2.52 million shares, yielding a market cap of $55.03 million.
Taking a glance at where the stock might be directed in the future, on a consensus basis, the sell-side has a one year price target of $2.33 on the stock, this valuation is based on 3 number of opinions. This consensus target price comprises projections from analysts polled by First Call.
In order to get a glimpse of Wall Street sentiment, we can look to brokerage analyst estimates. On a one to five ratings scale where 1 refers to a Strong Buy, 2 directs a Buy, 3 a Hold, 4 indicates a Sell and 5 a Strong Sell. Cytori Therapeutics Inc (NASDAQ:CYTX) currently has an average brokerage recommendation of 1.00 according to analysts. This is the average number based on the total brokerage firms taken into consideration by Zacks investment research.
Cytori Therapeutics, Inc. (CYTX) will provide a live webcast of its first quarter financial results and business update on Tuesday, May 10, 2016 at 5:30 PM Eastern Time.
Prior to the webcast at approximately 4:15 PM Eastern Time on May 10, Cytori will issue its first quarter earnings release which will review Cytori’s first quarter performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.
Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.
Technical Indicators & Financial Station
In order to check on the sell-side rational, we can also take a peek at some technical indicators. Cytori Therapeutics Inc (NASDAQ:CYTX)’s price sits 12.41% above from its 50-day moving average of $0.25 and -9.98% away from the stock’s 200-day moving average which is $0.25. Shares are trading -66.22% away from the 52-week high mark of $0.78 and +102.69 % far from the 52-week bottom of $0.13. The stock hit its 52-high on May 11, 2015, and 52-week low on Feb 12, 2016. The average true range, a measure of volatility is at 0.03, however its weekly and monthly volatility is 14.42%, 10.99% respectively. The company’s Relative Strength Index which shows price strength currently stands at 49.25. Relative Strength Index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock’s price movement.
While taking a glance at financials, we can look at a number of key indicators. The company has a Return on Assets of -47.40%, which is key indicator of how profitable a company is relative to its total assets. The company currently has a Return on Investment of -50.60%. ROI is a performance measure used to evaluate the efficiency of an investment or to compare the efficiency of a number of different investments. Cytori Therapeutics Inc (NASDAQ:CYTX)’s quick ratio for most recent quarter is 2.00 along with current ratio for most recent quarter of 2.50. Total debt to equity ratio of the company for most recent quarter is 1.52 whereas long term debt to equity r
Stock for Your Portfolio: Cytori Therapeutics Inc (NASDAQ:CYTX)
By Robin Evans -
May 9, 2016
Share on Facebook
Tweet on Twitter
Financial data analyzing. Counting on calculator. Close-up. Selective focus
Share of Cytori Therapeutics Inc (NASDAQ:CYTX) traded on 4.44 percent above secure line at 2:40PM EDT in order to take the company’s stock at the price of $0.261. At the time of writing the stock exchanged hands 1.91 million shares versus average trading capacity of 2.52 million shares, yielding a market cap of $55.03 million.
Taking a glance at where the stock might be directed in the future, on a consensus basis, the sell-side has a one year price target of $2.33 on the stock, this valuation is based on 3 number of opinions. This consensus target price comprises projections from analysts polled by First Call.
In order to get a glimpse of Wall Street sentiment, we can look to brokerage analyst estimates. On a one to five ratings scale where 1 refers to a Strong Buy, 2 directs a Buy, 3 a Hold, 4 indicates a Sell and 5 a Strong Sell. Cytori Therapeutics Inc (NASDAQ:CYTX) currently has an average brokerage recommendation of 1.00 according to analysts. This is the average number based on the total brokerage firms taken into consideration by Zacks investment research.
Cytori Therapeutics, Inc. (CYTX) will provide a live webcast of its first quarter financial results and business update on Tuesday, May 10, 2016 at 5:30 PM Eastern Time.
Prior to the webcast at approximately 4:15 PM Eastern Time on May 10, Cytori will issue its first quarter earnings release which will review Cytori’s first quarter performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.
Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.
Technical Indicators & Financial Station
In order to check on the sell-side rational, we can also take a peek at some technical indicators. Cytori Therapeutics Inc (NASDAQ:CYTX)’s price sits 12.41% above from its 50-day moving average of $0.25 and -9.98% away from the stock’s 200-day moving average which is $0.25. Shares are trading -66.22% away from the 52-week high mark of $0.78 and +102.69 % far from the 52-week bottom of $0.13. The stock hit its 52-high on May 11, 2015, and 52-week low on Feb 12, 2016. The average true range, a measure of volatility is at 0.03, however its weekly and monthly volatility is 14.42%, 10.99% respectively. The company’s Relative Strength Index which shows price strength currently stands at 49.25. Relative Strength Index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock’s price movement.
While taking a glance at financials, we can look at a number of key indicators. The company has a Return on Assets of -47.40%, which is key indicator of how profitable a company is relative to its total assets. The company currently has a Return on Investment of -50.60%. ROI is a performance measure used to evaluate the efficiency of an investment or to compare the efficiency of a number of different investments. Cytori Therapeutics Inc (NASDAQ:CYTX)’s quick ratio for most recent quarter is 2.00 along with current ratio for most recent quarter of 2.50. Total debt to equity ratio of the company for most recent quarter is 1.52 whereas long term debt to equity r
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
